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Abstract
Staphylococcus aureus is a human opportunistic pathogen that causes a wide range of superficial and systemic infections in 
susceptible patients. Here we describe how an inoculum of S. aureus activates the cellular and humoral response of Galleria 
mellonella larvae while growing and disseminating throughout the host, forming nodules and ultimately killing the host. An 
inoculum of S. aureus (2×106 larva− 1 ) decreased larval viability at 24 (80±5.77 %), 48 (55.93±5.55 %) and 72 h (10.23±2.97 %) and 
was accompanied by significant proliferation and dissemination of S. aureus between 6 and 48 h and the formation of nodules 
in the host. The hemocyte (immune cell) densities increased between 4 and 24 h and hemocytes isolated from larvae after 24 h 
exposure to heat-killed S. aureus (2×106 larva− 1 ) showed altered killing kinetics as compared to those from control larvae. Alter-
ations in the humoral immune response of larvae 6 and 24 h post-infection were also determined by quantitative shotgun prot-
eomics. The proteome of 6 h-infected larvae was enriched for antimicrobial proteins, proteins of the prophenoloxidase cascade 
and a range of peptidoglycan recognition proteins. By 24 h there was a significant increase in the abundance of a range of 
antimicrobial peptides with anti-staphylococcal activity and proteins associated with nodule formation. The results presented 
here indicate how S. aureus interacts with the larval immune response, induces the expression of a variety of immune-related 
peptides and also forms nodules which are a hallmark of soft tissue infections during human infection.
InTRoduCTIon
Staphylococcus aureus is a facultative anaerobic, Gram-
positive bacterium that colonizes approximately 30 % of the 
world’s population on a range of body sites. Staphylococcus 
is the most frequent cause of biofilm/medical device-related 
infections [1], most likely due to being a body commensal. 
The most frequent sites of S. aureus colonization are the nose, 
skin and gastrointestinal (GI) tract [2]. S. aureus colonization 
is mostly non-symptomatic, but in the correct situation it is 
capable of causing a wide variety of diseases, from furuncles 
and boils to serious infections such as pneumonia, toxic shock 
syndrome and endocarditis [3].
The virulence of S. aureus is multifaceted and comes from an 
arsenal of effectors which enable interactions with the host, 
immune cell evasion and the induction of tissue damage [4]. 
S. aureus 33 kDa protein alpha toxin can induce pro-inflam-
matory conditions and pore formation in mammalian cells, 
resulting in necrosis. It has been suggested that alpha toxin 
creates an enhanced infection microenvironment for disease 
progression [5]. A range of superantigens are able to induce 
inflammation, which can result in toxic shock syndrome 
and sepsis by non-specific activation of T-cell proliferation 
through interactions with MHC class II molecules on antigen 
presentation cells [6]. S. aureus can inhibit the mammalian 
complement pathway via chemotaxis inhibitory protein of 
staphylococci binding of the C5a receptor and staphylococcal 
complement inhibitor blocking of C3 convertase activity 
[7, 8]. Coagulase and von Willebrand factor binding protein 
activate fibrin clot formation, facilitating the formation of 
staphylococcal aggregates in the blood, and this is mediated 
by clumping factors A and B [9, 10]. Fibronectin-binding 
proteins A and B (FnBPA/B) bind to integrin α5β1, enabling 
the tethering of S. aureus to endothelial cells and phagocytic 
cells during infection [11].
Many experimental in vivo systems to characterize S. aureus 
infection dynamics have been developed, including cuta-
neous [12], renal [13] sepsis in mice [14] and endocarditis 
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in rats [15]. Alternative systems are also used and include 
models to study bloodstream infection and pathogenesis 
using zebrafish [16] and digestive tract infection in Caeno-
rhabditis elegans [17]. Insects are now widely employed to 
study different aspects of microbial pathogenesis [18–20]. 
The immune system of insects shares many similarities 
with the innate immune response of mammals and as a 
consequence insects may be used to assess the virulence 
of microbial pathogens and produce results comparable to 
those obtained using mammalian systems [21–23]. Larvae 
of Galleria mellonella (the greater wax moth) can be used to 
assess the virulence of fungal or bacterial pathogens, measure 
the in vivo toxicity of compounds and determine the in vivo 
activity of antimicrobial drugs [24–26]. G. mellonella larvae 
have many advantages as an in vivo model, as they are easy to 
inoculate, are free from legal and ethical restrictions, produce 
results in a short space of time, are amenable to incubation 
at 37 °C and, due to advances in ‘omic’ technologies, are now 
utilized to characterize the immune response to a variety of 
pathogens [24, 25]. G. mellonella larvae have used to study 
the virulence of Gram-positive bacteria such as Streptococcus 
pyogenes [27], Streptococcus pneumoniae [28], Enterococus 
faecalis [29, 30], Enterococcus faecium [31, 32], Staphylococcus 
aureus [33, 34] and Listeria monocytogenes [35, 36], and 
Gram-negative bacteria such as Pseudomonas aeruginosa 
[37, 38], Escherichia coli [39, 40], Klebsiella pneumoniae 
[41, 42], Legionella pneumophila [43, 44] and Acinetobacter 
baumanii [45, 46]. The aim of the work presented here was to 
examine the interaction of S. aureus with the larval immune 
Fig. 1. Effect of S. aureus cells on viability of G. mellonella larvae over 
72 h. G. mellonella larvae were inoculated with 20 µl S. aureus at doses 
ranging from 2×104 to 2×106 and incubated at 37 °C, and then viability 
was assessed over 72 h.
Fig. 2. S. aureus c.f.u. per larva obtained from G. mellonella larvae infected with S. aureus cells (2×106 larva−1) over 72 h. Infection with  
S. aureus resulted in an increase in bacterial load in larvae from 6 until 72 h, as determined by plating on nutrient agar plates. Statistical 
analysis was carried out by comparing each time point to the previous time point (*P<0.05, **P<0.01). All values are the mean ±se of 
three independent experiments.
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response and to characterize similarities with the mammalian 
response in order to better establish this system as a model 
for studying S. aureus infection processes.
METHodS
Larval culture and inoculation
Sixth instar larvae of the greater wax moth G. mellonella 
(Livefoods Direct Ltd, UK) were stored in the dark at 15 °C 
and maintained on wood chippings as previously reported 
[19, 23]. Larvae weighing 0.22±0.03 g were selected and used 
within 2 weeks of receipt. Ten healthy larvae per treatment 
and controls were placed in sterile 9 cm Petri dishes lined 
with Whatman filter paper and containing some wood shav-
ings. Larvae were inoculated with S. aureus through the last 
left pro-leg into the hemocoel with a Myjector U-100 insulin 
syringe (Terumo Europe N.V., Belgium). Larvae were accli-
matized to 37 °C for 1 h prior to all experiments and incu-
bated at 37 °C for all studies. All experiments were performed 
independently on three separate occasions.
S. aureus strains and culture conditions
S. aureus (clinical isolate) and green fluorescent protein 
(GFP)-tagged S. aureus strain SH1000 (a kind gift from 
Professor Joan Geoghegan, Trinity College Dublin, Ireland) 
were transferred aseptically using a sterile loop from a single 
colony grown on nutrient agar to nutrient broth (Oxoid) and 
grown overnight at 37 °C and 200 r.p.m. to the early stationary 
phase as previously described [47]. Cells were harvested by 
centrifugation (5000 g) and cell pellets were washed three 
times with phosphate-buffered saline (PBS) prior to injection 
into larvae. Stocks were maintained on nutrient agar plates.
determination of proliferation of S. aureus in G. 
mellonella larvae
An inoculum of 2×106 S. aureus cells larva−1 was achieved by 
inoculating larvae with 20 µl of a 0.01 OD600 suspension of S. 
aureus in PBS solution. Infected larvae (n=3) were homogenized 
in a pestle and mortar with 3 ml of PBS, serially diluted (10−4 
and 10−5), plated onto nutrient agar plates and incubated at 
37 °C for 24 h. The bacterial load was calculated as the number 
of S. aureus colony-forming units (c.f.u.) per larva and was based 
on the number of colonies that grew at specific dilutions. Samples 
of bacteria were plated onto CHROMagar plates to confirm their 
identity as S. aureus. Previous workers used selective media in 
this assay format [48], but a selective medium was not used 
here, as it was established that serial dilution of samples from 
uninfected larvae to the same levels as infected samples did not 
result in any indigenous bacteria growing on plates.
Cryo-imaging of S. aureus infection in G. mellonella
G. mellonella were inoculated with 2×106 S. aureus cells larva−1 
and incubated for 0, 6 and 24 h. Larvae (n=3) were embedded 
in Cryo-Imaging Embedding Compound (Bioinvision), 
flash-frozen in liquid nitrogen and mounted on a stage 
for sectioning according to the method described in [18]. 
Sectioning and imaging was carried out every 10 µm using a 
Cryoviz (Bioinvision, Inc., OH, USA) cryo-imaging system.
Confocal imaging of bacterial nodules
G. mellonella larvae (n=3) infected with S. aureus wild-type 
(WT) and GFP-labelled S. aureus (2×106 larva−1) for 6 and 
24 h were dissected in PBS and nodules were dissected apart 
with fine needles and transferred to a glass slide. The cells 
were washed twice (PBS) and a cover slide was placed on 
top. The cover slides were fixed in situ by applying a clear 
sealing solution around the perimeter of the slide, which also 
prevented the sample drying out. Cells were viewed with an 
Olympus Fluoview 1000 confocal microscope.
determination of hemocyte density
The larval hemocyte density was determined as described 
in [18, 19] by inoculation of viable S. aureus (2×106 larva−1). 
Changes in hemocyte density were assessed by bleeding 40 µl 
from each G. mellonella larva (n=5) into a micro-centrifuge 
tube on ice to prevent melanization. Hemolymph was diluted 
in 0.37 % (v/v) mercaptoethanol-supplemented PBS and cell 
density was determined using a hemocytometer. Hemocyte 
density was expressed in terms of hemocyte density/larva. 
Experiments were performed on three independent occasions 
and the means±standard error (se) were determined.
determination of microbicidal activity of hemocytes
Larvae were treated with heat-killed (95 °C, 15 min) S. aureus 
(2×106 larva−1) and hemocytes extracted 6 and 24 h post-inoc-
ulation. Hemocytes were mixed with pre-opsonized Candida 
albicans cells at a ratio of 2 : 1 in a thermally controlled stirring 
chamber at 37 °C. Aliquots were taken at t=0, 20, 40, 60 and 
80 min and plated on YEPD (Yeast extract, peptone, dextrose) 
agar plates supplemented with erythromycin (1 % w/v) as 
described in [18, 19].
Label-free quantitative (LFQ) proteomics of larval 
hemolymph
Label-free shotgun quantitative proteomics was conducted on 
hemocyte-free hemolymph from larvae (n=10) at 0, 6 and 24 
h post-infection with S. aureus (2×106 larva−1). Protein (75 µg) 
was prepared according to established protocols [19]. Protein 
identification from the tandem mass spectometry (MS/MS) 
data was performed using the Andromeda search engine in 
MaxQuant (version 1.2.2.5; http:// maxquant. org/) to corre-
late the data against a six-frame translation of the expressed 
sequence tag (EST) contigs for G. mellonella [49, 50].
Results processing, statistical analyses and graphics genera-
tion were conducted using Perseus v. 1.5.5.3. LFQ intensities 
were log2-transformed and analysis of variance (ANOVA) of 
significance and t-tests between the hemolymph proteomes 
of 0, 6 and 24 h S. aureus-treated larvae were performed using 
a P value of 0.05 and significance was determined using false 
discovery rate (FDR) correction (Benjamini–Hochberg). 
Proteins that had non-existent values (indicative of absence 
or very low abundance in a sample) were also used in 
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statistical analysis of the total differentially expressed group 
following imputation of the zero values using a number close 
to the lowest value of the range of proteins plus or minus the 
standard deviation. After data imputation these proteins were 
included in subsequent statistical analysis.
Statistical analysis
All experiments were performed on three independent 
occasions and the results are expressed as the mean±se. All 
statistical analysis was performed using GraphPad Prism 
v. 6.00 (one-way ANOVA analysis for hemocyte density and 
c.f.u. analysis and two-way ANOVA for hemocyte activity 
assay). Differences were considered significant at P<0.05.
data availability
The MS proteomics data and MaxQuant search output files 
have been deposited at the ProteomeXchange Consortium 
[51] via the PRIDE partner repository with the dataset identi-
fier PXD012766.
RESuLTS
Response of G. mellonella larvae to S. aureus 
infection
Larvae were inoculated with an inoculum of S. aureus 
(2×104–2×106 cells larva−1) and incubated at 37 °C, and then 
viability was assessed over 72 h. An inoculum of 2×104 cells 
larva−1 resulted in no change in larval viability over 72 h. 
An inoculum of 2×105 cells larva−1 resulted in no change 
in larval viability over 24 h, but at 48 and 72 h viability was 
reduced to 96.66±3.33 % and 84.43±2.94 %, respectively. 
An inoculum of 2×106 cells larva−1 resulted in the largest 
decrease in larval viability at 24 (80±5.77 %), 48 (55.93±5.55 
%) and 72 h (10.23±2.97 %) as compared to the control 
(Fig. 1).
Between 4 and 6 h post-infection, S. aureus c.f.u. larva−1 
increased from 3.14±0.19×105 to 5.08±0.28×105 (P<0.01). 
There was also an increase in S. aureus c.f.u. larva−1 at 24 
(1.31±0.11×108, P<0.01), 48 (2.76±0.18×108, P<0.01) and 
72 h (5.83±0.44×108, P<0.01) (Fig. 2).
dissemination of S. aureus infection through larvae
Cryo-imaging was employed to visualize the stages of inva-
sion and dissemination of S. aureus through G. mellonella 
larvae. Larvae were inoculated with viable S. aureus (2×106 
20 µl−1) as described (white arrows). Small discrete nodules 
appeared around the perimeter of the haemocoel 6 h post-
infection (black arrows), indicating the dissemination of 
S. aureus from the site of infection. By 24 and 48 h there 
was extensive melanization (red arrows) of larval tissue. The 
formation of large nodules at the site of inoculation was also 
apparent at 24 and 48 h post-infection (Fig. 3).
Confocal microscopy was employed at 6, 24 and 48 h post-
infection and revealed the presence of GFP-labelled viable 
S. aureus (blue arrows) within nodules formed during infec-
tion. Interestingly, at 6 h, cells were clumped together during 
the nodulation process (Fig. 4). WT S. aureus without GFP 
produced no fluorescence and was included as a control for 
auto-fluorescence (Fig. S1, available in the online version of 
this article).
Fig. 3. Cryoviz visualization of disseminated S. aureus infection of G. mellonella larvae at 6, 24 and 48 h. Larvae were inoculated with 
2×106 viable S. aureus cells for 6, 24 and 48 h and embedded, sectioned (10 µm) and visualized using a Cryoviz (Bioinvision, Inc., OH, USA) 
cryo-imaging system. White arrows, point of inoculation; black arrows, bacterial nodules; red arrows, extensive melanization.
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Alteration in hemocyte density and function in 
response to S. aureus infection
Inoculation of larvae with S. aureus (2×106 cells larva−1) 
resulted in a spike in hemocyte density at 4 h 1.47±0.25×106 
larva−1 (60 µl hemolymph), P<0.05] as compared to the 
control (4.71±0.66×105). There was also an increase in hemo-
cyte density at 6 h (6.23±8.61×105, P<0.05) compared to the 
control (2.81±0.15×105). Larvae infected with S. aureus for 
24 (6.65±1.66×105, P<0.05) and 72 h (1.29±0.16×106, P<0.05) 
showed a significant increase in hemocyte density compared 
to the controls (Fig. 5).
Hemocytes from larvae that were treated with heat-killed S. 
aureus (2×106 20 µl−1) for 24 h displayed an increased ability 
to kill yeast cells as compared to hemocytes from control 
larvae and larvae treated with S. aureus for 6 h. Hemocytes 
from larvae treated with S. aureus for 24 h reduced the 
viability of C. albicans to 3.49±0.69 % (P<0.01) at 60 min and 
1.39±1.39 % (P<0.05) at 80 min compared to the controls 
at the same time points (60 min, 53.98±10.62 %; 80 min, 
25.63±6.14 %) (Fig. 6).
Incubation of hemocytes with S. aureus (2 : 1 ratio) for 5 and 
20 min indicated hemocyte lysis around S. aureus cells (white 
Fig. 4. Visualization of GFP-labelled S. aureus cells within bacterial nodules in G. mellonella larvae inoculated with 2×106 viable cells. 
Bacterial nodules were dissected from larvae infected with S. aureus for 6, 24 and 48 h and visualized using confocal microscopy. 
Brightfield images reveal the formation of melanized plaques (green arrow). Fluorescent microscopy revealed an abundance of S. aureus 
cells (blue arrows) within nodules at 6, 24 and 48 h post-infection (scale bar corresponds to 10 µm).
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arrows) (Figs 7 and S2). This process has been also reported 
elsewhere with fungal cells [18].
Humoral immune response of larvae to S. aureus 
infection
Quantitative proteomics was performed on hemocyte-free 
hemolymph (hemocytes were removed by centrifugation at 
10 000 g for 10 min) from larvae infected with S. aureus 
(2×106 larva−1) at 0, 6 and 24 h. In total, 331 proteins were 
identified consisting of 2121 peptides. Of these, 18 proteins 
for 6 vs 0 h and 33 proteins for 24 vs 0 h were found to be 
differentially abundant with a fold change >1.5. In total, 12 
proteins were found to be exclusive to 6 and 24 h treatments. 
A principal component analysis (PCA) of the proteins present 
at all three time points indicated that there was a distinct 
difference between the proteomes at 0, 6 and 24 h (Fig. S3).
Proteins that showed increased abundance in the 6 h-infected 
larvae when compared to the uninfected control larvae 
included hypothetical protein (43-fold increase), gloverin 
(14 -old increase), gustatory receptor candidate 25 (10-fold 
increase), peptidoglycan-recognition protein-LB (9-fold 
increase), peptidoglycan recognition-like protein B (5-fold 
increase) and beta actin (4-fold increase) (Table  1). The 
Fig. 5. Alteration in circulating hemocyte density following inoculation with viable S. aureus cells. G. mellonella larvae were inoculated 
with 20 µl S. aureus cells (2×106) or PBS and hemocytes were extracted and enumerated from 0 to 72 h post-inoculation. Statistical 
analysis was performed by comparing treatments to PBS-injected controls at respective time points (*P<0.05). All values are the mean 
±se of three independent experiments.
Fig. 6. Microbicidal activity of hemocytes extracted from G. mellonella 
larvae at 0, 6 and 24 h after inoculation with heat-killed S. aureus cells 
(2×106 larva−1). Pre-opsonized C. albicans cells were incubated with 
hemocytes (2 : 1 ratio) for 80 min and aliquots were taken every 20 min, 
diluted and plated on YEPD agar plates (*P<0.05, **P<0.01). All values 
are the mean ±se of three independent experiments.
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proteins that showed decreased abundance at 6 h compared 
to 0 h were alpha esterase 45 (1.6-fold decrease) and hypothet-
ical protein (2-fold decrease) (Fig. 8). Proteins that showed 
increased abundance in the 24 h-infected larvae compared 
to 0 h included gloverin (86-fold increase), cecropin-D like 
peptide (79-fold increase), hypothetical protein (46-fold 
increase), cecropin-A (30-fold increase), gloverin-like protein 
(23-fold increase), lysozyme (18-fold increase), peptidoglycan 
recognition-like protein B (17-fold increase), peptidoglycan-
recognition protein-LB (15-fold increase), inducible metal-
loproteinase inhibitor protein (10-fold increase) and hemolin 
(9-fold increase) (Table 2). The proteins that showed decreased 
abundance at 24 h compared to 0 h were cathepsin B-like 
cysteine proteinase (4-fold decrease), heat shock protein 25.4 
precursor (3-fold decrease), hypothetical protein (2.7-fold 
decrease), serine proteinase (2.7-fold decrease) and hypo-
thetical protein (2.3-fold decrease) (Fig. 8).
dISCuSSIon
In recent years G. mellonella larvae, and other insect species, 
have been employed to assess the virulence of a range of 
bacterial species and produce results that correlate with those 
generated using mice [22, 52]. While G. mellonella larvae offer 
a number of advantages that overcome the drawbacks associ-
ated with mammalian testing and other model systems, there 
is now the opportunity to model bacterial infection processes 
in larvae and to characterize similarities with this process in 
mammals.
Infection with S. aureus dose-dependently decreased larval 
viability at 37 °C. In mice, an inoculum of 108 c.f.u. per mouse 
resulted in 50 % survival after 2 days and 0 % survival after 4 
days [53]. Bacterial load peaked at 72 h and this is associated 
with a significant decrease in larval viability. In neutrophil-
depleted mice, S. aureus can significantly proliferate within 
blood and skin samples [54].
At 6 h post-infection there were small nodules around the 
site of inoculation but no melanization of the cuticle. At 6 h 
S. aureus appeared in clumps, but by 24 h single cells were 
present within nodules and this occurred with extensive 
melanized nodule formation around the hemocoel of the 
larvae. By 48 h widespread melanization of insect hemolymph 
had occurred, possibly due to uncontrolled phenoloxidase 
activation due to an uncontrollable bacterial burden. A small 
number of nodules were produced as compared to infection 
by fungal pathogens and this may have been due to clumping 
of S. aureus cells.
Nodules produced in G. mellonella larvae during infection are 
similar in structure and function to the abscesses commonly 
found during S. aureus skin and soft tissue infection in 
Fig. 7. Response of ex vivo hemocytes to S. aureus. Hemocytes were extracted from G. mellonella larvae washed three times with PBS 
and mixed for 5 and 20 min at a 1 : 1 ratio. Brightfield images of GFP-labelled S. aureus suggest the lysis of hemocytes around S. aureus 
cells (white arrows) (scale bar corresponds to 10 µm).
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humans [55]. S. aureus produces several molecules that 
contribute to abscess formation and these recruit neutrophils 
and induce host cell lysis and the formation of the fibrin 
capsules that surround the abscesses [55]. Abscess formation 
is associated with a characteristic decrease in S. aureus c.f.u. 
load, but this may be associated with an increase within 
tissue [56]. This was also observed in this study as the total 
S. aureus c.f.u. decreased in larvae between 2 and 4 h. S. aureus 
Table 1. Proteins which were considered statistically significant and differentially abundant (SSDA) in G. mellonella larvae hemolymph infected with S. 
aureus for 6 h as compared to 0 h (Red:increased in abundance,Green; decreased in abundance)
Protein name No. of peptides Sequence coverage 
(%)
Score P value Fold change
Gloverin 3 46.2 42.566 5.27E-05 20.06
Gustatory receptor 6 40.9 62.929 0.0002057 18.14
Uncharacterized protein 6 22.7 100.94 0.0115559 16.19
Serpin-4B 5 78.8 41.117 0.007772 6.63
Peptidoglycan-recognition protein-LB 3 72.4 39.312 0.024767 5.97
Peptidoglycan recognition-like protein B 13 34 296.93 0.0013876 5.41
Uncharacterized protein 3 19 75.959 0.0154921 4.76
Beta actin 9 52 261.97 0.0024351 4.61
AGAP011516-PA 5 14.5 38.671 0.0316638 3.99
Prophenol oxidase-activating enzyme 3 5 44.4 55.786 0.0316365 2.85
Protease inhibitor 1 15 37 169.5 0.0313505 2.56
Uncharacterized protein 3 21.2 183.66 0.0427484 2.1
Serine protease inhibitor dipetalogastin 3 15.5 40.032 0.0185339 1.98
Fructose-1,6-bisphosphatase 12 28 323.31 0.0083192 1.92
Arginine kinase 2 29.1 53.86 0.0300812 1.82
Putative hydroxypyruvate isomerase 10 71.1 224.42 0.0128579 1.68
Carboxylic ester hydrolase 11 31.5 103.82 0.0202315 1.63
Alpha-esterase 45 5 8.5 48.709 0.002778 −1.63
Fig. 8. Proteomic responses of G. mellonella larval hemolymph following infection by 2×106 S. aureus cells after 6 (a) and 24 h (b). Volcano 
plots represent protein intensity difference (log
2
 mean intensity difference) and significance in differences (log P value) based on a two-
sided t-test. Proteins above the line are considered statistically significant (P value<0.05) and those to the right and left of the vertical 
lines indicate relative fold changes >1.5. Annotations are given for the most differentially abundant proteins identified in hemolymph 
from larvae infected with S. aureus for 6 and 24 h. These plots are based upon post-imputed data.
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Table 2. Proteins which were considered statistically significant and differentially abundant in G. mellonella larvae hemolymph infected with S. aureus 
for 24 h as compared to 0 h (Red: increased in abundance, Green; decreased in abundance)
Protein name No. of peptides Sequence coverage 
(%)
Score P value Fold change
Gloverin 3 46.2 42.566 2.05E-05 121.69
Cecropin-d-like peptide 2 14.5 81.412 4.40E-05 73.7
Lysozyme 6 19.1 45.237 4.73E-05 31.38
Moricin-like peptide B 1 13.3 14.208 0.001982 20.81
Peptidoglycan recognition-like protein B 13 34 296.93 2.12E-05 17.35
Uncharacterized protein 6 22.7 100.94 0.009474 17.23
Inducible metalloproteinase inhibitor protein 7 35.1 99.811 0.001234 14.61
Gustatory receptor 6 40.9 62.929 0.000171 13.3
Cecropin-A (cecropin-C) 1 8.5 9.4615 0.005058 10.56
Uncharacterized protein 3 19 75.959 2.23E-05 9.88
Peptidoglycan-recognition protein-LB 3 72.4 39.312 0.014231 9.53
Hemolin 5 53.6 106.13 0.002471 9.23
Hemolin 16 51.5 323.31 0.001797 8.39
Putative defence protein Hdd11 6 34.2 53.851 0.024342 7.24
Serpin-4B 5 78.8 41.117 0.007182 7.03
Yellow-d 12 26.6 196.65 0.016128 6.96
Protease inhibitor 1 3 21.2 183.66 0.000272 5.81
Prophenol oxidase-activating enzyme 3 15 37 169.5 0.007552 4.97
Peptidoglycan recognition protein 11 56 313.13 0.0015 4.64
Chemosensory protein 7 4 21 181.63 0.012462 4.5
Gloverin 2 14.8 13.135 0.005864 3.83
Sulfhydryl oxidase 1 5 26.2 105.27 0.002125 3.54
Prophenoloxidase-activating protease I 2 57.7 21.028 0.006467 3.46
Serine protease inhibitor dipetalogastin 12 28 323.31 0.012544 2.68
Beta-1,3-glucan recognition protein 19 41.4 315.64 0.001665 2.16
Inducible serine protease inhibitor 2 3 9.8 111.22 0.00849 1.72
Hemolymph proteinase 16 10 38.2 146.66 0.0024 1.57
Serine proteinase 14 34 323.31 0.019384 −2.7
Uncharacterized protein 2 5.6 58.117 0.014143 −2.71
Cathepsin B-like cysteine proteinase 4 13.8 41.669 0.017993 −2.79
Heat shock protein 25.4 13 48 323.31 0.016116 −2.93
BmP109 7 23.4 60.397 0.019927 −3.72
Thioredoxin 3 13.6 35.124 0.014066 −3.94
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invasion triggers predominantly neutrophils and macrophage 
infiltration and this is associated with residence of S. aureus 
within neutrophils. Within 72 h staphylococci are localized 
within abscesses at the centre of the lesions, enclosed by fibrin 
deposits and surrounded by layers of immune cells [56, 57].
Inoculation of larvae with 2×106 S. aureus cells resulted in 
a significant increase in the numbers of circulating hemo-
cytes at 4 h, possibly due to the release of hemocytes usually 
attached to the linings of internal organs such as body fat 
[58]. There was also an increase in hemocyte density at 6 and 
24 h post-infection and this was correlated with the repli-
cation of S. aureus cells within larvae. Interestingly, human 
neutrophils (which are analogous to insect hemocytes) 
are first recruited to the site of S. aureus infection and the 
accumulation of neutrophils is effective in S. aureus killing 
[59–61]. In G. mellonella larvae hemocytes can be differenti-
ated into at least five types of cells, including prohemocytes 
(precursor cells), granulocytes, which are usually spherical 
with lobulated nuclei, and plasmatocytes (the most abundant 
cell type in the hemolymph), which are small round-shaped 
pseudopodia-producing cells with adherent properties, 
and engage in phagocytosis, encapsulation and nodulation 
processes [62–64]. In mice infected with 107 or 108 S. aureus 
cells, circulating granulocyte density peaked at 6 h and was 
higher in mice infected with the higher dose [53]. BALB/c 
mice infected with S. aureus (108) displayed a significant 
increase in neutrophil density before a spike in S. aureus 
proliferation was observed [65], and in this study hemocyte 
density peaked prior to accelerated S. aureus proliferation.
Hemocytes from larvae exposed to heat-killed S. aureus 
for 24 h were more microbicidal than control hemocytes 
and hemocytes from larvae exposed for 6 h, indicating the 
possible appearance of a specific cell type (e.g. granulocyte) 
with superior killing ability. Interactions between S. aureus 
and larval hemocytes resulted in hemocyte degranulation and 
lysis, and this is the early stage of nodule formation around 
the microbial invader (Fig. 7), which is also observed with 
fungal cells [18].
Proteomic analysis of larval hemolymph at 6 and 24 h post-
infection with S. aureus revealed a range of proteins that 
are involved in regulation of the immune response, defence 
against bacterial infection and nodule formation. There was 
also an increase in a range of opsonins, such as peptidoglycan-
recognition protein-LB and peptidoglycan recognition-like 
protein B, at 6 h post-infection, which play an important role 
in bacterial cell identification and recognition by circulating 
immune cells [66]. Components of the prophenoloxidase 
cascade (prophenoloxidase-activating enzyme 3) were also 
increased in abundance in the proteome of 6 h S. aureus-
infected hemolymph. The phenoloxidase cascade is analogous 
to the mammalian complement cascade in terms of protein 
structure, function and mode of action [67, 68]. S. aureus 
interacts with and evades the complement cascade at many 
levels [69]. At 6 h post-infection the antimicrobial protein 
showing the greatest increase in abundance was gloverin. 
Gloverin is a glycine-rich, heat-stable antibacterial protein 
believed to bind lipopolysaccharides (LPS) and it was previ-
ously demonstrated that E. coli induced its expression in 
Bombyx mori [70].
By 24 h post-infection a range of antimicrobial peptides 
(AMPs), such as gloverin, cecropin-d-like peptide, lysozyme 
and moricin-like peptide B, showed increased abundance. 
The AMP family cecropin were first isolated from Hyalophora 
cecropia and demonstrate antibacterial activity against 
multidrug-resistant Acinetobacter baumannii and P. aerugi-
nosa and display immunomodulatory effects on macrophages 
[71]. Cecropin A displays antimicrobial activity against 
S. aureus [72], but protoplasts are resistant to cecropin B [73]. 
Lysozyme was also increased in abundance in response to 
S. aureus infection and cleaves the β−1,4 glycosidic bonds 
between N-acetylmuramic acid and N-acetylglucosamine of 
bacterial peptidoglycan and induces bacterial lysis. However, 
many S. aureus strains display intrinsic resistance to lysozyme 
and its activity acts in synergy with other AMPs and the 
cellular immune response [74, 75]. Moricins are secreted pro-
peptides that are are activated via proteolysis and increase the 
permeability of bacterial membranes [76]. B. mori moricin 
is active against S. aureus, targets the membrane and is 
induced by bacterial infection [76]. A range of human AMPs 
are essential in the defence against Staphylococcus infection. 
Pathogenic S. aureus primarily induce human β-defensin 
(hBD) 1 and hBD3. LL-37 is expressed on the skin and is 
an important defence against S. aureus invasion, displaying 
important bactericidal activity against S. aureus [77]. 
S. aureus induces the expression of hBD3 and hCAP-18, while 
methicillin-resistant S. aureus is more resistant to AMPs than 
its methicillin-susceptible counterpart [78].
A number of proteins involved in nodule formation in 
G. mellonella larvae were also increased in abundance, such 
as putative defence protein hdd11 and hemolin. Hdd11 
was increased in hemolymph at 24 h post-infection with 
S. aureus and has been found to be increased in Hyphan-
tria cunea during bacterial infection and shares homology 
with noduler from Antheraea mylitta [79, 80]. Noduler 
shares a reeler domain with Hdd11 and binds both insect 
hemocytes and bacterial LPS, is enriched within nodules 
and is important during the nodulation response [81]. The 
immunoglobulin superfamily member hemolin was induced 
by Candida challenge and has been shown to act as a pattern 
recognition receptor in insects [82, 83]. Hdd11 and hemolin 
have also showed increased abundance in larvae infected 
with Aspergillus fumigatus and C. albicans. Fungal infection 
of larvae also results in a more dramatic increase in AMPs, 
proteins associated with cellular stress, invasion of fungal 
hyphae and a range of β-glucan binding proteins [18, 19].
The results presented here detail the cellular and humoral 
responses of larvae to S. aureus during the development 
of disseminated disease. These results show similarities to 
the interaction of S. aureus with the immune response in 
mammals (i.e. rapid bacterial proliferation, nodule forma-
tion, alteration in immune cell numbers and increased anti-
microbial peptide abundance). Studying the development 
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of S. aureus infection in larvae may give novel insights 
into the pathogen–host interactions that could improve 
our understanding of this disease process in mammals. 
These similarities may also be used to study the efficacy and 
interaction of novel antibiotics with S. aureus in combina-
tion with the host immune response, while overcoming 
the disadvantages associated with using mice in early-stage 
drug development.
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